Projects per year
Personal profile
Education
- 2006-2008 M.S., Graduate Institute of Clinical Medicine, College of Medicine, Taipei Medical University
- 1990-1997 M.D., School of Medicine, College of Medicine, Taipei Medical University
Experience
- Director, Department of Pathology, Taipei Medical University Shuang Ho Hospital
- 2020.05- Assistant Professor, Department of Pathology, School of Medicine, College of Medicine, Taipei Medical University
- 2012.08-2013.07 Research Scholar/Visiting Scholar, Department of Pathology, Brown University
- 2008.02-2020.05 Instructor, Department of Pathology, School of Medicine, College of Medicine, Taipei Medical University
- Attending Physician, Department of Pathology, Taipei Medical University-Shuang Ho Hospital, Ministry of Health and Welfare
- 2007.11-2011.01 Attending Physician, Department of Pathology, Taipei Medical University Hospital
- 2003.06-2007.10 Attending Physician, En Chu Kong Hospital
- 2002.12-2003.05 Attending Physician, Taipei Medical University Hospital
- 1998.03-2002.11 Resident Physician, Taipei Medical University Hospital
Fingerprint
Dive into the research topics where Phui-Ly Liew is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Projects
- 2 Finished
-
Molecular Classification of Endometrial Cancer by Bhlhe22 Subtypes in Normal Endometrium
Liew, P.-L. (PI)
8/1/21 → 7/31/22
Project: A - Government Institution › b - National Science and Technology Council
-
新聘教師研究補助
Liew, P.-L. (PI)
5/1/21 → 4/30/22
Project: B - Project of TMU › g - Research Grants for Newly Hired Faculty
-
The expression of BHLHE22 in endometrial carcinoma: Associations with mismatch repair protein expression status, tumor-infiltrating immune cells, programmed death-ligand 1 and clinical outcomes
Chen, L. Y., Chen, H. Y., Lai, H. C., Lin, S. F., Wen, K. C., Darmawi & Liew, P. L., 2025, In: Taiwanese Journal of Obstetrics and Gynecology. 64, 1, p. 110-119 10 p.Research output: Contribution to journal › Article › peer-review
-
Active DNA Demethylase, TET1, Increases Oxidative Phosphorylation and Sensitizes Ovarian Cancer Stem Cells to Mitochondrial Complex I Inhibitor
Chen, L. Y., Shen, Y. A., Chu, L. H., Su, P. H., Wang, H. C., Weng, Y. C., Lin, S. F., Wen, K. C., Liew, P. L. & Lai, H. C., Jun 2024, In: Antioxidants. 13, 6, 735.Research output: Contribution to journal › Article › peer-review
Open Access1 Citation (Scopus) -
Correction to: In vitro drug testing using patient-derived ovarian cancer organoids (Journal of Ovarian Research, (2024), 17, 1, (194), 10.1186/s13048-024-01520-2)
Chen, L. Y., Chou, Y. T., Liew, P. L., Chu, L. H., Wen, K. C., Lin, S. F., Weng, Y. C., Wang, H. C., Su, P. H. & Lai, H. C., Dec 2024, In: Journal of Ovarian Research. 17, 1, 243.Research output: Contribution to journal › Comment/debate › peer-review
Open Access -
In vitro drug testing using patient-derived ovarian cancer organoids
Chen, L. Y., Chou, Y. T., Liew, P. L., Chu, L. H., Wen, K. C., Lin, S. F., Weng, Y. C., Wang, H. C., Su, P. H. & Lai, H. C., Dec 2024, In: Journal of Ovarian Research. 17, 1, 194.Research output: Contribution to journal › Article › peer-review
Open Access1 Citation (Scopus) -
Pulmonary lymphoepithelioma-like carcinoma: A complication of Epstein–Barr virus in a teenager
Chen, S. H., Miser, J. S., Liew, P. L., Chen, B. J. & Liu, Y. L., Aug 2023, In: Journal of Microbiology, Immunology and Infection. 56, 4, p. 886-888 3 p.Research output: Contribution to journal › Letter › peer-review
Open Access1 Citation (Scopus)
Datasets
-
Additional file 1 of Complete remission of heavily treated ovarian clear cell carcinoma with ARID1A mutations after pembrolizumab and bevacizumab combination therapy: a case report
Lin, Y.-C. (Contributor), Wen, K.-C. (Creator), Sung, P.-L. (Contributor), Chou, Y.-T. (Creator), Liew, P.-L. (Contributor), Chen, L.-Y. (Contributor), Huang, R.-L. (Creator), Lai, H.-C. (Contributor) & Chang, L.-T. (Contributor), Figshare, 2020
DOI: 10.6084/m9.figshare.13352142.v1, https://springernature.figshare.com/articles/figure/Additional_file_1_of_Complete_remission_of_heavily_treated_ovarian_clear_cell_carcinoma_with_ARID1A_mutations_after_pembrolizumab_and_bevacizumab_combination_therapy_a_case_report/13352142/1
Dataset
-
Complete remission of heavily treated ovarian clear cell carcinoma with ARID1A mutations after pembrolizumab and bevacizumab combination therapy: a case report
Lin, Y.-C. (Contributor), Wen, K.-C. (Creator), Sung, P.-L. (Contributor), Chou, Y.-T. (Creator), Liew, P.-L. (Contributor), Chen, L.-Y. (Contributor), Huang, R.-L. (Creator), Lai, H.-C. (Contributor) & Chang, L.-T. (Contributor), Figshare, 2020
DOI: 10.6084/m9.figshare.c.5234313.v1, https://springernature.figshare.com/collections/Complete_remission_of_heavily_treated_ovarian_clear_cell_carcinoma_with_ARID1A_mutations_after_pembrolizumab_and_bevacizumab_combination_therapy_a_case_report/5234313/1
Dataset